According to CytomX Therapeutics 's latest financial reports the company's current earnings are โฌ0.12 Billion. In 2023 the company made an earning of -โฌ6.24 Million, an increase over its 2022 earnings that were of -โฌ0.12 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | โฌ6.04 M | -196.86% |
2023 | -โฌ6.24 Million | -94.62% |
2022 | -โฌ0.12 Billion | 43.84% |
2021 | -โฌ80.6 Million | 72.37% |
2020 | -โฌ46.76 Million | -52.66% |
2019 | -โฌ98.77 Million | 31.83% |
2018 | -โฌ74.92 Million | 68.34% |
2017 | -โฌ44.51 Million | -20.95% |
2016 | -โฌ56.3 Million | 73.99% |
2015 | -โฌ32.36 Million |